Menard Financial Group LLC Has $686,000 Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Menard Financial Group LLC increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,134 shares of the company’s stock after purchasing an additional 40 shares during the quarter. Menard Financial Group LLC’s holdings in HCA Healthcare were worth $686,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in HCA Healthcare by 0.4% in the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after purchasing an additional 60,304 shares in the last quarter. Sanders Capital LLC raised its position in HCA Healthcare by 4.2% during the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after acquiring an additional 456,738 shares in the last quarter. Wellington Management Group LLP grew its position in HCA Healthcare by 1.7% in the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock worth $2,757,181,000 after acquiring an additional 170,560 shares in the last quarter. Royal Bank of Canada lifted its stake in shares of HCA Healthcare by 35.7% in the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after purchasing an additional 1,183,890 shares during the last quarter. Finally, Capital World Investors increased its position in HCA Healthcare by 57.5% during the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after buying an additional 1,019,750 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on HCA. Robert W. Baird assumed coverage on HCA Healthcare in a report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price objective on the stock. Barclays upped their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. UBS Group boosted their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Wells Fargo & Company boosted their price objective on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. Finally, JPMorgan Chase & Co. lifted their price target on HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a research report on Thursday, May 30th. Five equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $359.89.

Insider Buying and Selling

In other news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock worth $6,407,273 in the last 90 days. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $394.68 on Monday. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The stock’s fifty day simple moving average is $362.19 and its 200 day simple moving average is $338.12. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $403.05. The firm has a market cap of $101.86 billion, a price-to-earnings ratio of 19.67, a P/E/G ratio of 1.46 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period last year, the firm posted $4.29 EPS. On average, analysts expect that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.67%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s payout ratio is presently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.